Skip Navigation



NDT Advance Access published online on March 19, 2004
Nephrology Dialysis Transplantation, doi:10.1093/ndt/gfh209
© 2004 by European Renal Association - European Dialysis and Transplant Association
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
19/6/1559    most recent
gfh209v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Aggarwal, A.
Right arrow Articles by Schneider, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aggarwal, A.
Right arrow Articles by Schneider, D. J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Received November 29, 2003
Accepted February 11, 2004

Original Article

Attenuation of platelet reactivity by enoxaparin compared with unfractionated heparin in patients undergoing haemodialysis

Atul Aggarwal 1*, Deborah A. Whitaker 1, Jeffrey M. Rimmer 1, Richard J. Solomon 1, F. John Gennari 1, Burton E. Sobel 1, David J. Schneider 1

1 Department of Medicine, University of Vermont College of Medicine, Burlington, VT, USA

* To whom correspondence should be addressed. E-mail: vipulatul7{at}yahoo.com.



  Abstract

Background. Increased platelet reactivity presages adverse cardiac events. Because both haemodialysis and unfractionated heparin (UFH) can increase platelet reactivity, we compared platelet reactivity during haemodialysis when patients were anticoagulated with UFH or enoxaparin.

Methods. Patients (n = 20) underwent consecutive haemodialysis sessions with either UFH or enoxaparin in a random order. Blood was taken from the arterial end of the haemodialysis circuit at the initiation of haemodialysis before anticoagulation. Subsequently, blood was taken during dialysis from the venous end of the circuit 10 min after treatment with UFH or enoxaparin. Platelet reactivity was assessed with the use of flow cytometry by determining the capacity of platelets to bind fibrinogen and the surface expression of P-selectin in response to adenosine diphosphate (ADP, 0 and 0.2 µM). Results were compared with the use of two-way repeated measure ANOVA.

Results. Platelet reactivity in arterial blood obtained at the beginning of dialysis prior to patients being treated with either UFH [0.2 µM ADP-induced capacity to bind fibrinogen = 28±15% (SD)] or enoxaparin (30±18%) was similar (P = 0.15). In contrast, platelet reactivity was less after treatment with enoxaparin compared with UFH (P = 0.006). The 0.2 µM ADP-induced capacity to bind fibrinogen in venous blood obtained 10 min after anticoagulation was 34±11% after treatment with UFH and 22±11% after treatment with enoxaparin.

Conclusions. Anticoagulation with enoxaparin during haemodialysis is associated with less platelet reactivity compared with UFH. Accordingly, enoxaparin use may contribute to a lesser risk of cardiac events in patients with end-stage renal disease treated with haemodialysis.

Keywords: enoxaparin; kidney; platelets


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Nephrol Dial TransplantHome page
M. Gritters, P. Borgdorff, M. P. C. Grooteman, M. Schoorl, M. Schoorl, P. C. M. Bartels, G.-J. Tangelder, and M. J. Nube
Platelet activation in clinical haemodialysis: LMWH as a major contributor to bio-incompatibility?
Nephrol. Dial. Transplant., September 1, 2008; 23(9): 2911 - 2917.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.